Locarnini, Stephen

Publishing since 1993 (Senior)

Has published 103 publications in 18 years

Number of publications published per year by Locarnini, Stephen. (Source : PubMed)

Distribution of publications types for Locarnini, Stephen. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Crane M, Sirivichayakul S, Chang JJ, Avihingsanon A, Ubolyam S, Buranapraditkun S, Thantiworasit P, Wightman F, Locarnini S, Matthews G, Dore GJ, Ruxrungtham K, Lewin SR. No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.  J. Virol.  2010;84;6  
•  Revill P, Yuen L, Walsh R, Perrault M, Locarnini S, Kramvis A. Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses.  J. Med. Virol.  2010;82;1  
•  Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues.  Gastroenterology  2009;137;5  
•  Nguyen T, Locarnini S. Hepatitis: Monitoring drug therapy for hepatitis B--a global challenge?  Nat Rev Gastroenterol Hepatol  2009;6;10  
•  Nguyen T, Desmond P, Locarnini S. The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B.  Hepatology international  2009  
•  Matthews GV, Seaberg E, Dore GJ, Bowden S, Lewin SR, Sasadeusz J, Marks P, Goodman Z, Philp FH, Tang Y, Locarnini S, Thio CL. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.  AIDS  2009;23;13  
•  Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, Locarnini S, Dore GJ, Ruxrungtham K, Lewin SR. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.  J. Virol.  2009;83;15  
•  Kamili S, Sozzi V, Thompson G, Campbell K, Walker CM, Locarnini S, Krawczynski K. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.  Hepatology  2009;49;5  
•  Thompson AJ, Colledge D, Rodgers S, Wilson R, Revill P, Desmond P, Mansell A, Visvanathan K, Locarnini S. Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro.  Antivir. Ther. (Lond.)  2009;14;6  
•  Warner N, Locarnini S. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?  Antivir. Ther. (Lond.)  2009;14;2  

[ See timeline ] [ See all publications ]